NASDAQ:HSGX
Delisted

Histogenics Corporation Stock Forecast

$3.22
+0.165 (+5.40%)
At Close: Feb 25, 2022
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Volatile ride for Histogenics Corporation stock price on Friday moving between $2.93 and $3.26
(Updated on Feb 25, 2022)

Sell candidate since Feb 23, 2022 Gain 2.88% PDF

The Histogenics Corporation stock price gained 5.40% on the last trading day (Friday, 25th Feb 2022), rising from $3.06 to $3.22. During the last trading day the stock fluctuated 11.26% from a day low at $2.93 to a day high of $3.26. The price has fallen in 7 of the last 10 days and is down by -16.8% for this period. Volume fell on the last day by -8 million shares and in total, 14 million shares were bought and sold for approximately $45.29 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -42.30% during the next 3 months and, with a 90% probability hold a price between $1.14 and $2.36 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

HSGX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Histogenics Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.49 and $3.67. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 22, 2022, and so far it has fallen -23.88%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Histogenics Corporation stock

Histogenics Corporation finds support from accumulated volume at $3.13 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.330 between high and low, or 11.26%. For the last week, the stock has had daily average volatility of 11.81%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HSGX) For The Upcoming Trading Day Of Monday 28th

For the upcoming trading day on Monday, 28th we expect Histogenics Corporation to open at $3.14, and during the day (based on 14 day Average True Range), to move between $2.80 and $3.64, which gives a possible trading interval of +/-$0.417 (+/-12.96%) up or down from last closing price. If Histogenics Corporation takes out the full calculated possible swing range there will be an estimated 25.93% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.28 (1.86%) than the support at $3.13 (2.80%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Histogenics Corporation stock A Buy?

Histogenics Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.617 Strong Sell Candidate Unchanged

Predicted Opening Price for Histogenics Corporation of Monday, February 28, 2022

Fair opening price February 28, 2022 Current price
$3.14 ( 2.59%) $3.22

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for HSGX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.47 7.66 %
R2 3.34 3.75 %
R1 3.26 1.33 %
Current price: 3.22
Support S1 3.01 -6.50 %
S2 2.93 -8.92 %
S3 2.81 -12.84 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.87 20.19 %
R2 3.55 10.25 %
R1 3.28 1.86 %
Current price 3.22
Support S1 3.13 -2.80%
S2 3.06 -5.12%
S3 2.95 -8.39%

FAQ

What is the symbol for Histogenics Corporation Stock and on which exchange is it traded?
The symbol for Histogenics Corporation is HSGX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Histogenics Corporation Stock?
Histogenics Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Histogenics Corporation Stock?
Histogenics Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Histogenics Corporation Stock.

What's the current price of Histogenics Corporation Stock?
As of the end of day on the 2022-02-25, the price of an Histogenics Corporation (HSGX) share was $3.22.

What is the 52-week high and low for Histogenics Corporation Stock?
The 52-week high for Histogenics Corporation Stock is $17.65 and the 52-week low is $2.87.
Click to get the best stock tips daily for free!

About Histogenics Corporation

Histogenics Histogenics Corporation, a regenerative medicine company, focuses on developing and commercializing products in the musculoskeletal segment of the marketplace. Its product candidate includes NeoCart, which is in Phase III clinical trials, intended to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. The company has an exclusive channel collaboration agreement with Intrexon Corporation for the development ... HSGX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT